Shandra Eisenga TB Study Act of 2026

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 9561 Introduced in House (IH)]

<DOC>

119th CONGRESS
2d Session
H. R. 9561

To direct the Secretary of Health and Human Services to conduct a study
on the feasibility of developing an accurate and reliable standardized
test for detecting tuberculosis in tissue from a human cadaver, and for
other purposes.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

June 30, 2026

Mr. Moolenaar (for himself and Mrs. Dingell) introduced the following
bill; which was referred to the Committee on Energy and Commerce

_______________________________________________________________________

A BILL

To direct the Secretary of Health and Human Services to conduct a study
on the feasibility of developing an accurate and reliable standardized
test for detecting tuberculosis in tissue from a human cadaver, and for
other purposes.

Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the ``Shandra Eisenga TB Study Act of
2026''.

SEC. 2. NIH STUDY ON DEVELOPMENT OF STANDARDIZED TUBERCULOSIS TEST FOR
HUMAN CADAVER TISSUE.

(a) Study.--Not later than 2 years after the date of the enactment
of this Act, the Secretary of Health and Human Services (in this
section referred to as the ``Secretary'') shall conduct a comprehensive
study on the feasibility of developing an accurate and reliable
standardized test, or testing strategy, for detecting tuberculosis in
tissue from a human cadaver (in this section referred to as a ``TB
test'') for the purpose of improving donor screening, transplant
safety, and the integrity of organ and tissue donation systems.
(b) Consultation.--The Secretary shall conduct the study under
subsection (a) in consultation with--
(1) the Director of the National Institutes of Health;
(2) the Director of the Centers for Disease Control and
Prevention;
(3) the Commissioner of Food and Drugs;
(4) the Administrator of the Health Resources and Services
Administration; and
(5) relevant stakeholders that have experience with tissue
or organ donations and post-mortem systems, including organ
procurement organizations and tissue banks.
(c) Elements.--In conducting the study under subsection (a), the
Secretary may include, as appropriate--
(1) assess the current state of scientific knowledge and
any research gap related to TB tests;
(2) evaluate methodologies for testing tissue from a human
cadaver;
(3) consider any issue related to implementing such a
methodology with respect to a TB test, including specimen
collection, timing requirements for testing, quality assurance,
and biosafety;
(4) assess the feasibility of conducting pilot and
implementation studies on TB tests using tissue collected
from--
(A) individuals across diverse populations,
including high-risk and underserved communities; and
(B) multiple clinical and tissue recovery sites,
including hospitals, organ procurement organizations,
tissue banks, and offices of medical examiners;
(5) develop recommendations for interagency coordination,
as appropriate, to support the validation, review, and
implementation of a TB test; and
(6) identify any additional scientific, operational, or
regulatory barrier to the development and implementation of a
TB test.
(d) Report.--Not later than 3 years after the date of enactment of
this Act, the Secretary shall submit to Congress a report describing--
(1) the findings and conclusions of the Secretary based on
the study; and
(2) a recommendation for developing and implementing a TB
test, including any congressional or regulatory action
necessary to address any barrier to such development or
implementation.
(e) Funding.--For each of fiscal years 2027 through 2031, the
Secretary may use amounts appropriated to support the Department of
Health and Human Services to carry out this section, subject to the
availability of appropriations.
<all>